FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.
This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.
Anglo American plc with ticker (LON:AAL) now has a potential upside of 15.2% according to Berenberg Bank.Berenberg Bank set a target price of 2,400 GBX for the company, which when..
AstraZeneca plc (LON:AZN) has announced its 9M and Q3 2023 results. Revenue and EPS summary 9M 2023 Q3 2023 % Change % Change $m Actual CER[1] $m Actual ..
Taylor Wimpey plc (LON:TW) has announced its latest trading statement. Jennie Daly, CEO, commented: “Taylor Wimpey has delivered a resilient performance in what continues to be a challenging market backdrop,..
B&M European Value Retail S.A. (LON:BME), the UK’s leading variety goods value retailer, has announced its interim results for the 26 weeks to 23 September 2023. Highlights · Group revenues..
National Grid plc (LON:NG), a leading energy transmission and distribution company, has announced its Half-Year results for the period ended 30 September 2023. John Pettigrew, Chief Executive, said: “Today we’ve..
AstraZeneca plc (LON:AZN) and Eccogene have entered into an exclusive licence agreement for ECC5004, an investigational oral once-daily glucagon-like peptide 1 receptor agonist (GLP-1RA) for the treatment of obesity, type-2..
Persimmon Plc (LON:PSN) has announced the appointment of Andrew Duxbury as Chief Financial Officer (CFO). Andrew will join the Board as an Executive Director, with his start date to be..
Marks and Spencer Group Plc (LON:MKS) has announced its half year results for 26 weeks ended 30 September 2023. Strong first half results · Profit before tax and adjusting items of..
RS Group plc (LON:RS1) has announced its results for the half year ended 30th September 2023. Highlights H1 2023/24 H1 2022/23 Change Like-for-like1 change Revenue £1,447m £1,458m (1)% (8)% Adjusted operating..
Beazley plc (LON:BEZ) has announced its trading statement for the nine months ended 30 September 2023. Overview · Insurance written premiums increased by 9% to $4,325m (Q3 2022: $3,978m) ·..
Associated British Foods plc (LON:ABF) has confirmed: (i) a final dividend of 33.1 pence per share will be paid; and (ii) in addition to the final dividend, a special dividend of 12.7 pence per share..
Scottish Mortgage Investment Trust PLC (LON:SMT) has announced its results for the six months to 30 September 2023. The following is the unaudited Interim Financial Report for the six months..
Pearson plc (LON:PSON), the world’s leading learning company, will host an investor seminar today at the New York Stock Exchange for analysts and investors on its largest and most profitable..
Melrose Industries PLC (LON:MRO) has announced that its GKN Aerospace Engines business has signed a major new agreement with GE Aerospace, the global aerospace engines market leader. Background and scope..
British American Tobacco plc (LON:BATS) has advised that Soraya Benchikh has been appointed to the role of Chief Financial Officer and Executive Director and will join the BAT p.l.c. and..
J Sainsbury Plc (LON:SBRY) has announced its interim results for the 28 weeks ended 16 September 2023. We’re gaining volume from all of our grocery competitors, have grown ahead of..
Entain plc (LON:ENT), the global sports betting and gaming group, has reported trading for the period from 1 July to 30 September 2023 and provides an update on accelerating the..
Smith & Nephew plc (LON:SN, NYSE:SNN), the global medical technology business, has announced that John Rogers will succeed Anne-Françoise Nesmes as Chief Financial Officer. He will join the company as..
Next plc (LON:NXT) has announced its third quarter trading statement. HEADLINES ● Full price sales1 in the third quarter (August – October) were up +4.0% on last year, £23m ahead of our..
AstraZeneca plc (LON:AZN) has announced a collaboration and investment agreement with Cellectis, a clinical-stage biotechnology company, to accelerate the development of next generation therapeutics in areas of high unmet need,..
